Clinical studies have consistently demonstrated that RA patients exhibit the levels of IL-23 and IL-17 significantly elevated in both their blood and synovial fluid samples, compared to healthy individuals (Abdo and Tye, 2020). Here, IL17A is linked to rheumatoid arthritis.